Macquarie Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-509
| Closed | -$11K | – | 1711 |
|
|
2025
Q1 | $11K | Sell |
509
-146
| -22% | -$3.16K | ﹤0.01% | 1640 |
|
|
2024
Q4 | $13K | Buy |
655
+155
| +31% | +$3.08K | ﹤0.01% | 1577 |
|
|
2024
Q3 | $12K | Buy |
+500
| New | +$12K | ﹤0.01% | 1620 |
|
|
2022
Q4 | – | Sell |
-4,020
| Closed | -$56K | – | 2074 |
|
|
2022
Q3 | $56K | Sell |
4,020
-333
| -8% | -$4.64K | ﹤0.01% | 1917 |
|
|
2022
Q2 | $42K | Hold |
4,353
| – | – | ﹤0.01% | 2096 |
|
|
2022
Q1 | $43 | Hold |
4,353
| – | – | ﹤0.01% | 2184 |
|
|
2021
Q4 | $51K | Hold |
4,353
| – | – | ﹤0.01% | 2157 |
|
|
2021
Q3 | $50K | Buy |
4,353
+4,020
| +1,207% | +$46.2K | ﹤0.01% | 2233 |
|
|
2021
Q2 | $5K | Hold |
333
| – | – | ﹤0.01% | 2526 |
|
|
2021
Q1 | $6K | Sell |
333
-158
| -32% | -$2.85K | ﹤0.01% | 2437 |
|
|
2020
Q4 | $9K | Hold |
491
| – | – | ﹤0.01% | 2313 |
|
|
2020
Q3 | $8K | Hold |
491
| – | – | ﹤0.01% | 2300 |
|
|
2020
Q2 | $13K | Buy |
+491
| New | +$13K | ﹤0.01% | 2251 |
|